𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CXCR3 ligands promote expression of functional indoleamine 2,3-dioxygenase in basal cell carcinoma keratinocytes

✍ Scribed by B.K.K. Lo; R.B. Jalili; D. Zloty; A. Ghahary; B. Cowan; J.P. Dutz; N. Carr; J. Shapiro; K.J. McElwee

Book ID
108671881
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
605 KB
Volume
165
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High expression of IMPACT protein promot
High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death
✍ Darya Habibi; Reza B. Jalili; Farshad Forouzandeh; Christopher J. Ong; Aziz Ghah πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 358 KB

## Abstract Indoleamine 2,3‐dioxygenase (IDO), a tryptophan degrading enzyme, is a potent immunomodulatory factor. IDO expression in fibroblasts selectively induces apoptosis in immune cells but not in primary skin cells. However, the mechanism(s) of this selective effect of IDO‐induced low tryptop

High expression of indoleamine 2,3-dioxy
High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma
✍ Jocelyne Jacquemier; FranΓ§ois Bertucci; Pascal Finetti; Benjamin Esterni; Emmanu πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 500 KB

## Abstract Medullary breast cancer (MBC) is a basal‐like breast carcinoma (BLBC) with a favourable outcome, whereas nonmedullary BLBC has a poor prognosis. Tumour infiltrating lymphocytes (TILs) are present in both MBC and BLBC. We hypothesized that the immunosuppressive enzyme indoleamine 2,3‐dio